Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study
Hematological Oncology · 2025
DOI: 10.1002/hon.70087 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Hematological Oncology, 2025. Verfasst von Pallawi Torka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Marginal Zone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Given the paucity of age‐specific data about biology, presentation, and treatment outcomes in adults with MZL, we sought to evaluate differences between younger (≤ 70 years) and older (> 70 years) patients with MZL in a large retrospective cohort treated in the contemporary era (2010 onwards). The primary objective was progression‐free survival (PFS), while secondary objectives included the evaluation of overall survival (OS) and the cumulative incidence of transformation between the 2 groups. A total of 598 patients were included in the analysis and among these 32% were > 70 years of age. There were no age‐based differences in the prevalence of NMZL, SMZL, and EMZL. Older patients had a higher incidence of adverse prognostic features at diagnosis such as worse performance status, advanced stage disease, and bone marrow involvement, yet were more likely to be treated with single‐agent rituximab than chemoimmunotherapy. Age > 70 years was associated with inferior PFS and OS after controlling for clinically relevant risk factors and accounting for differences in first‐line treatment. Receipt of rituximab monotherapy was associated with significantly inferior PFS overall, however, the type of first‐line therapy did not impact OS in any group. Our data suggests that despite the development of new drugs for MZL, age remains an independent predictor of inferior outcomes. Investigation of targeted therapy combinations in the first‐line setting may yield the required balance of efficacy and toxicity in older adults with MZL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
- Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
- Department of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
ORCID-Profile: Timothy J Voorhees, Reem Karmali, Adam J Olszewski, Narendranath Epperla
Förderung
- NCI NIH HHS
Zitieren
APA
Torka, P., Grover, N. S., Voorhees, T. J., Karmali, R., Annunzio, K., Watkins, M. P., Anampa-Guzmán, A., Reves, H., Tavakkoli, M., Christian, B., Thomas, C., Barta, S. K., Geethakumari, P. R., Bartlett, N. L., Shouse, G., Olszewski, A. J., & Epperla, N. (2025). Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study. Hematological Oncology. https://doi.org/10.1002/hon.70087
Vancouver
Torka P, Grover NS, Voorhees TJ, Karmali R, Annunzio K, Watkins MP, et al. Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study. Hematological Oncology. 2025. doi:10.1002/hon.70087
BibTeX
@article{Torka2025,
author = {Torka, Pallawi and Grover, Natalie S and Voorhees, Timothy J and Karmali, Reem and Annunzio, Kaitlin and Watkins, Marcus P and Anampa-Guzmán, Andrea and Reves, Heather and Tavakkoli, Montreh and Christian, Beth and Thomas, Colin and Barta, Stefan K and Geethakumari, Praveen Ramakrishnan and Bartlett, Nancy L and Shouse, Geoffrey and Olszewski, Adam J and Epperla, Narendranath},
title = {Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study},
journal = {Hematological Oncology},
year = {2025},
doi = {10.1002/hon.70087}
}
EUVIMED